Maravai LifeSciences Announces Preliminary Unaudited 2024 Revenue
| MRVI Stock | USD 5.62 0.01 0.18% |
Under 61% of Maravai Lifesciences' investor base is looking to short. The analysis of overall sentiment of trading Maravai Lifesciences Holdings stock suggests that many investors are alarmed at this time. Maravai Lifesciences' investing sentiment shows overall attitude of investors towards Maravai Lifesciences Holdings.
Maravai |
Announces Earnings Release Date SAN DIEGO, Jan. 08, 2025 -- Maravai LifeSciences Holdings, Inc. , a global provider of lif
Read at gurufocus.com
 |
Maravai Lifesciences Fundamental Analysis
We analyze Maravai Lifesciences' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Maravai Lifesciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Maravai Lifesciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Price To Earning
Price To Earning Comparative Analysis
Maravai Lifesciences is currently under evaluation in price to earning category among its peers. Price to Earnings ratio is typically used for current valuation of a company and is one of the most popular ratios that investors monitor daily. Holding a low PE stock is less risky because when a company's profitability falls, it is likely that earnings will also go down as well. In other words, if you start from a lower position, your downside risk is limited. There are also some investors who believe that low Price to Earnings ratio reflects the low pricing because a given company is in trouble. On the other hand, a higher PE ratio means that investors are paying more for each unit of profit.
Maravai Lifesciences Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Maravai Lifesciences stock to make a market-neutral strategy. Peer analysis of Maravai Lifesciences could also be used in its relative valuation, which is a method of valuing Maravai Lifesciences by comparing valuation metrics with similar companies.
Peers
Maravai Lifesciences Related Equities
| CYTK | Cytokinetics | 6.04 | ||||
| ARQT | Arcutis Biotherapeutics | 1.84 | ||||
| INSM | Insmed | 0.82 | ||||
| ASND | Ascendis Pharma | 0.56 | ||||
| HALO | Halozyme Therapeutics | 0.25 | ||||
| INCY | Incyte | 0.08 | ||||
| AKRO | Akero Therapeutics | 0.08 | ||||
| DNLI | Denali Therapeutics | 0.13 | ||||
| KRYS | Krystal Biotech | 0.16 | ||||
| PTGX | Protagonist Therapeutics | 0.29 | ||||
| ROIV | Roivant Sciences | 0.36 | ||||
| FOLD | Amicus Therapeutics | 0.41 | ||||
| ARGX | Argenx NV | 0.50 | ||||
| EWTX | Edgewise Therapeutics | 0.52 | ||||
| ABUS | Arbutus Biopharma | 0.60 | ||||
| ALEC | Alector | 1.10 | ||||
| IMVT | Immunovant | 1.50 | ||||
| HRMY | Harmony Biosciences | 1.68 | ||||
| RARE | Ultragenyx | 1.78 | ||||
| LEGN | Legend Biotech | 2.07 | ||||
| APLS | Apellis Pharmaceuticals | 2.47 | ||||
| AGIO | Agios Pharm | 2.60 |
Complementary Tools for Maravai Stock analysis
When running Maravai Lifesciences' price analysis, check to measure Maravai Lifesciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Maravai Lifesciences is operating at the current time. Most of Maravai Lifesciences' value examination focuses on studying past and present price action to predict the probability of Maravai Lifesciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Maravai Lifesciences' price. Additionally, you may evaluate how the addition of Maravai Lifesciences to your portfolios can decrease your overall portfolio volatility.
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities |